Showing 1 - 15 results of 15 for search 'C.M. Ong', query time: 0.07s
Refine Results
-
1
-
2
-
3
The Controversial Role of Fibrosis in Autosomal Dominant Polycystic Kidney Disease by Maria Fragiadaki, Fiona M. Macleod, Albert C. M. Ong
Published 2020-11-01
Article -
4
Polycystin-1 regulates ARHGAP35-dependent centrosomal RhoA activation and ROCK signaling by Andrew J. Streets, Philipp P. Prosseda, Albert C.M. Ong
Published 2020-08-01
Article -
5
-
6
-
7
-
8
Emulsification of Bio-Oil and Diesel by Y.Y. Chong, S. Thangalazhy-Gopakumar, H.K. Ng, P.B. Ganesan, S. Gan, L.Y. Lee, V.S.A.R. Manickavel, C.M. Ong, H.S. Al Hinai
Published 2017-03-01
Article -
9
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model by Phil McEwan, Hayley Bennett Wilton, Albert C. M. Ong, Bjarne Ørskov, Richard Sandford, Francesco Scolari, Maria-Cristina V. Cabrera, Gerd Walz, Karl O’Reilly, Paul Robinson
Published 2018-02-01
Article -
10
Identification of renal cyst cells of type I Nephronophthisis by single-nucleus RNA sequencing by Qianying Wang, Baojuan Zou, Xiaoya Wei, Hongrong Lin, Changmiao Pang, Lei Wang, Jinglin Zhong, Huamu Chen, Xuefei Gao, Min Li, Albert C. M. Ong, Zhihui Yue, Liangzhong Sun
Published 2023-07-01
Article -
11
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD by Ronald D. Perrone, Dorothee Oberdhan, John Ouyang, Daniel G. Bichet, Klemens Budde, Arlene B. Chapman, Berenice Y. Gitomer, Shigeo Horie, Albert C.M. Ong, Vicente E. Torres, A. Neil Turner, Holly Krasa
Published 2023-05-01
Article -
12
The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKDPlain-Language Sum... by Ronald D. Perrone, Ali Hariri, Pascal Minini, Curie Ahn, Arlene B. Chapman, Shigeo Horie, Bertrand Knebelmann, Michal Mrug, Albert C.M. Ong, York P.C. Pei, Vicente E. Torres, Vijay Modur, Ronald T. Gansevoort
Published 2022-10-01
Article -
13
Tuberous Sclerosis Complex (TSC): Expert Recommendations for Provision of Coordinated Care by Nicholas M. P. Annear, Nicholas M. P. Annear, Richard E. Appleton, Zahabiyah Bassi, Rupesh Bhatt, Patrick F. Bolton, Pamela Crawford, Alex Crowe, Maureen Tossi, Maureen Tossi, Frances Elmslie, Frances Elmslie, Eric Finlay, Daniel P. Gale, Alex Henderson, Elizabeth A. Jones, Elizabeth A. Jones, Simon R. Johnson, Simon R. Johnson, Shelagh Joss, Larissa Kerecuk, Graham Lipkin, Patrick J. Morrison, Finbar J. O'Callaghan, Jill Cadwgan, Jill Cadwgan, Jill Cadwgan, Albert C. M. Ong, Albert C. M. Ong, Julian R. Sampson, Charles Shepherd, J. Chris Kingswood, J. Chris Kingswood, J. Chris Kingswood
Published 2019-11-01
Article -
14
HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized co... by Thomas Bais, Esther Meijer, Bart J. Kramers, Priya Vart, Marc Vervloet, Mahdi Salih, Bert Bammens, Nathalie Demoulin, Polina Todorova, Roman-Ulrich Müller, Jan Halbritter, Alexander Paliege, Emilie Cornec-Le Gall, Bertrand Knebelmann, Roser Torra, Albert C. M. Ong, Fiona E. Karet Frankl, Ron T. Gansevoort
Published 2024-02-01
Article -
15
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the Europe... by Roman-Ulrich Müller, A. Lianne Messchendorp, Henrik Birn, Giovambattista Capasso, Emilie Cornec-Le Gall, Olivier Devuyst, Albertien van Eerde, Patrick Guirchoun, Tess Harris, Ewout J. Hoorn, Nine V.A.M. Knoers, Uwe Korst, Djalila Mekahli, Yannick Le Meur, Tom Nijenhuis, Albert C.M. Ong, John A. Sayer, Franz Schaefer, Aude Servais, Vladimir Tesar, Roser Torra, Stephen B. Walsh and Ron T. Gansevoort
Published 2022-02-01
Article